Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI studyMatteo Clavarezza, Marco Venturini, Vincenzo Adamo et al.|BMC Cancer|2012Cited by 8
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancerFrancesco Grossi, Enzo Galligioni, Filippo de Marinis et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 3
P2-19-04: Changes in Adjuvant Treatment of Early Breast Cancer in Italy between 2000 and 2008. The NEMESI Study Versus the NORA Study.Giorgio Mustacchi, Davide Dondi, Ferdinando Riccardi et al.|Cancer Research|2011Cited by 0